ZTS Stock Chart & Fundamental Analysis

Fundamentals Charts

About ZOETIS INC CLASS A

Name

ZOETIS INC CLASS A

CEO

Kristin C. Peck

Website

www.zoetis.com

Industry

Healthcare

Year Founded

1952

Employees

14,500

Zoetis Inc. develops, makes, and sells animal health medicines and related tools, operating in the healthcare sector as a maker of animal therapeutics and diagnostics listed on the NYSE under ZTS. Its business spans veterinary pharmaceuticals, diagnostics, nutrition, and animal health technology, and generated $9.5 billion in FY2025.

Analyst Ratings

Consensus Recommendation

Buy0

Hold2

Sell6

Fundamentals & Financials

Revenue (TTM)

$9.5B

Net Income (TTM)

$2.6B

EPS (TTM)

$6.08

ROA (TTM)

17.35%

Current Ratio

3.08

Dividend Yield

0.74%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$2,468M	$2,262M	$2,387M
Cost of Sales	$673,000K	$641,000K	$743,000K
Gross Profit	$1,795M	$1,621M	$1,644M
Operating Income	$937,000K	$822,000K	$826,000K
Net Income	$691,000K	$601,000K	$603,000K
EPS	$1.65	$1.42	$1.38

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

ZOETIS INC CLASS A's Technical Indicators Summary

ZTS is rated Strong Sell at 73.96 driven by clear downside momentum and broad moving-average weakness. Short-term momentum and MACD are negative while RSI sits below neutral, and the stock trades beneath its short-, medium- and long-term moving averages including the 200-day, signaling pervasive underperformance. ADX is low, indicating the decline lacks trending strength, yet ATR implies moderate intraday volatility of roughly 3.9%, so moves can be meaningful. On-balance volume shows persistent outflows, reinforcing the bearish picture. Technical takeaway: Strong Sell — below major moving averages with negative momentum and selling pressure evident.

Buy

0 signals

Neutral

2 signals

Sell

6 signals

Overall: Bearish75% Bearish signals

Indicator	Value	Signal	Explanation
RSI (14)	45.94	Neutral	RSI (45.94) is neutral.
Stochastic %K (14, 3, 3)	26.87	Neutral	Stochastic (26.87) is neutral.
CCI (20)	-81.24	—	CCI (-81.24) is neutral.
WPR (14)	-67.72	—	Williams %R (-67.72) is neutral.
Momentum (10)	-2.08	—	Momentum (-2.08) is negative.
MFI	41.33	—	MFI (41.33) is neutral.
MACD Level (12, 26)	-0.78	Sell	Confirmed downtrend: MACD (-0.78) is negative and below its signal line (-0.66).
Bollinger Bands	$72.16 - $78.59	—	Price is within the bands.
ATR (14)	$2.87 (3.88%)	—	Moderate Volatility (3.88%).
ADX (14)	10.47	—	Weak or consolidating trend (ADX < 25). ADX(10.47), +DI(23.17), -DI(25.71)
OBV	-151,433,146	—	Bearish volume pressure: OBV is below its 20-day SMA. OBV(-151,433,146), 20D-SMA-OBV(-151,081,809)
Classic Pivot Point	$72.36	—	Price ($73.96) has broken above resistance R1 ($73.71) — bullish breakout potential.
Fibonacci Pivot Point	$72.36	—	Price ($73.96) has broken above resistance R1 ($73.16) — bullish breakout potential.
Simple Moving Averages	$74.46 - $106.25(5 indicators)	—	SMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key SMA averages.
Exponential Moving Averages	$74.50 - $105.10(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

ZTS managed a small uptick in the last trading session, closing at 73.96, up 1.36% from 72.97. ZTS gains on news that Main Street Financial Solutions LLC made a new investment in Zoetis.

Trading Volume

Below 10d avg (8.4M)

3.2M

vs S&P 500 Today

Outperforming Market

+2.05%

52-Week Position

Near lows

3.3%

Updated: August 19, 2026 at 12:48 UTC